Shenzhen Neptunus Bioengineering Co Ltd (000078) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.006x

Based on the latest financial reports, Shenzhen Neptunus Bioengineering Co Ltd (000078) has a cash flow conversion efficiency ratio of -0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-16.37 Million ≈ $-2.40 Million USD) by net assets (CN¥2.85 Billion ≈ $416.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shenzhen Neptunus Bioengineering Co Ltd (000078) market capitalisation for the company's overall valuation and market capitalisation.

Shenzhen Neptunus Bioengineering Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shenzhen Neptunus Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen Neptunus Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Neptunus Bioengineering Co Ltd ranked by their cash flow conversion efficiency. Explore 000078 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
TOMTOM N.V.ADRS 1/2 EO-20 F:OEMB	0.065x
Guangdong Piano Customized Furniture Co Ltd SHE:002853	0.016x
CJ CGV KO:079160	0.005x
Kunming Yunnei Power Co Ltd SHE:000903	-0.122x
Kvika banki hf IC:KVIKA	0.046x
Fujian SuperTech Advanced Material Co Ltd SHG:688398	0.016x
Mattr Corp TO:MATR	0.106x
Jiujiang Shanshui Technology Co.Ltd SHE:301190	-0.002x

Annual Cash Flow Conversion Efficiency for Shenzhen Neptunus Bioengineering Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Neptunus Bioengineering Co Ltd from 1998 to 2025. View latest Shenzhen Neptunus Bioengineering Co Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.18 Billion ≈ $318.49 Million	CN¥104.39 Million ≈ $15.28 Million	0.048x	+244.96%
2024-12-31	CN¥2.84 Billion ≈ $416.13 Million	CN¥39.54 Million ≈ $5.79 Million	0.014x	+114.30%
2023-12-31	CN¥4.22 Billion ≈ $617.14 Million	CN¥-410.19 Million ≈ $-60.02 Million	-0.097x	-823.85%
2022-12-31	CN¥6.11 Billion ≈ $894.15 Million	CN¥-64.33 Million ≈ $-9.41 Million	-0.011x	-108.88%
2021-12-31	CN¥7.31 Billion ≈ $1.07 Billion	CN¥866.12 Million ≈ $126.74 Million	0.119x	-46.22%
2020-12-31	CN¥7.49 Billion ≈ $1.10 Billion	CN¥1.65 Billion ≈ $241.53 Million	0.220x	-23.74%
2019-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥2.27 Billion ≈ $331.97 Million	0.289x	+282.22%
2018-12-31	CN¥7.16 Billion ≈ $1.05 Billion	CN¥-1.14 Billion ≈ $-166.11 Million	-0.159x	+57.83%
2017-12-31	CN¥6.47 Billion ≈ $946.76 Million	CN¥-2.43 Billion ≈ $-356.01 Million	-0.376x	-47.65%
2016-12-31	CN¥5.88 Billion ≈ $860.13 Million	CN¥-1.50 Billion ≈ $-219.06 Million	-0.255x	-703.04%
2015-12-31	CN¥2.14 Billion ≈ $313.60 Million	CN¥90.51 Million ≈ $13.24 Million	0.042x	+164.08%
2014-12-31	CN¥1.78 Billion ≈ $260.85 Million	CN¥-117.48 Million ≈ $-17.19 Million	-0.066x	-1.10%
2013-12-31	CN¥1.89 Billion ≈ $276.27 Million	CN¥-123.07 Million ≈ $-18.01 Million	-0.065x	+15.69%
2012-12-31	CN¥1.06 Billion ≈ $154.67 Million	CN¥-81.73 Million ≈ $-11.96 Million	-0.077x	+60.55%
2011-12-31	CN¥971.04 Million ≈ $142.09 Million	CN¥-190.33 Million ≈ $-27.85 Million	-0.196x	-531.98%
2010-12-31	CN¥902.62 Million ≈ $132.08 Million	CN¥40.96 Million ≈ $5.99 Million	0.045x	-84.77%
2009-12-31	CN¥692.59 Million ≈ $101.35 Million	CN¥206.34 Million ≈ $30.19 Million	0.298x	+13.26%
2008-12-31	CN¥780.79 Million ≈ $114.25 Million	CN¥205.39 Million ≈ $30.05 Million	0.263x	+369.89%
2007-12-31	CN¥903.62 Million ≈ $132.23 Million	CN¥50.59 Million ≈ $7.40 Million	0.056x	-10.00%
2006-12-31	CN¥868.76 Million ≈ $127.13 Million	CN¥54.04 Million ≈ $7.91 Million	0.062x	+39.82%
2005-12-31	CN¥805.26 Million ≈ $117.83 Million	CN¥35.82 Million ≈ $5.24 Million	0.044x	+205.31%
2004-12-31	CN¥1.45 Billion ≈ $212.47 Million	CN¥-61.34 Million ≈ $-8.98 Million	-0.042x	-114.41%
2003-12-31	CN¥1.44 Billion ≈ $211.22 Million	CN¥-28.44 Million ≈ $-4.16 Million	-0.020x	+63.65%
2002-12-31	CN¥2.06 Billion ≈ $301.91 Million	CN¥-111.83 Million ≈ $-16.36 Million	-0.054x	-29.21%
2001-12-31	CN¥1.97 Billion ≈ $288.97 Million	CN¥-82.84 Million ≈ $-12.12 Million	-0.042x	+90.83%
2000-12-31	CN¥238.75 Million ≈ $34.94 Million	CN¥-109.25 Million ≈ $-15.99 Million	-0.458x	-367.67%
1999-12-31	CN¥205.69 Million ≈ $30.10 Million	CN¥-20.13 Million ≈ $-2.95 Million	-0.098x	+54.56%
1998-12-31	CN¥177.08 Million ≈ $25.91 Million	CN¥-38.13 Million ≈ $-5.58 Million	-0.215x	--

About Shenzhen Neptunus Bioengineering Co Ltd

SHE:000078 China Drug Manufacturers - Specialty & Generic

Market Cap

$585.22 Million

CN¥4.00 Billion CNY

Market Cap Rank

#11531 Global

#3271 in China

Share Price

CN¥1.52

Change (1 day)

+0.00%

52-Week Range

CN¥1.29 - CN¥5.29

All Time High

CN¥9.81